Immune-mediated inflammatory diseases (IMIDs) are a group of chronic conditions driven by immune dysregulation and inflammation. While they may affect different organs and be treated by different clinical specialties, many IMIDs share underlying inflammatory pathways and can coexist within the same patient.
Patients with IMIDs often experience complex and evolving disease trajectories that require long-term management. Care may involve multiple healthcare settings and clinical specialties, and some patients may develop additional IMIDs affecting different organ systems. As a result, understanding disease progression, treatment patterns, healthcare utilisation and clinical outcomes requires longitudinal real-world data that extends beyond individual clinical encounters. Real-world evidence (RWE) is critical in addressing these knowledge gaps. By leveraging routinely collected healthcare data, RWE provides comprehensive insights into patient management and outcomes in routine clinical practice.
One way to support the generation of holistic RWE is through a Healthcare Observatory: a platform that longitudinally and retrospectively collects, harmonises, integrates, and clinically validates healthcare data from multiple sources, making it available for research and analysis. At LOGEX, we have developed an Observatory specifically for IMIDs, a multi-country RWE platform designed to support research and provide a more complete understanding of disease progression, treatment pathways, and patient journeys in routine clinical practice.
The Observatory offers:
🔹 Coverage across three therapeutic areas
Integrated data spanning dermatology, rheumatology, and gastroenterology, enabling the study of IMIDs within and across therapeutic areas.
🔹 A holistic view of the patient journey
Longitudinal, multi-source data that provides a comprehensive view of patients over time, capturing disease progression, treatment patterns and healthcare utilisation across specialties.
🔹 Actionable insights across the care pathway
Robust RWE that supports the evaluation of disease burden, treatment effectiveness, clinical outcomes, unmet needs, and healthcare resource utilisation, informing clinical and healthcare decision-making.​‌
Together, these capabilities provide a foundation for generating RWE that can support a more informed understanding and management of IMIDs across the continuum of care.
💡 Explore the Illustration below to learn more about the LOGEX IMID Observatory.
👉 Want to know more? Get in touch.